Brief: TScan Therapeutics Announces 2024 Clinical Plans
04/01/2024 12:42
Jan 4 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS ANNOUNCES 2024 CLINICAL PLANS AND
HIGHLIGHTS
RECENT PROGRESS
* TSCAN THERAPEUTICS INC - CLOSED UNDERWRITTEN PUBLIC
OFFERING
WITH NET PROCEEDS OF $140.6 MILLION, FUNDING OPERATIONS INTO
2026
Source text for Eikon: ID:nGNXJDrmQ
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing